Allergy Diagnostics Market – Global Outlook & Forecast 2021-2031

Allergy Diagnostics Market – Global Outlook & Forecast 2021-2031

Market Introduction

Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, molds, animal proteins, foods, medications, etc. When an allergic individual comes in contact with an allergen, the immune system mounts a response through the IgE antibody. People who are prone to allergies are called as allergic or "atopic." The allergic symptoms may include runny nose, sneezing, blocked sinuses, itching, watery eyes, etc. An allergy diagnostic test may involve either a skin test or a blood test which helps to diagnose particular pollens, molds, or other allergens a particular person is allergic to. Once the allergen is determined, doctors may come up with a plan for avoiding those allergens and can also prescribe medications to ease the symptoms.

Market - Headwinds & Tailwinds

The global allergy diagnostics market is mainly driven by rising incidence of allergies across the globe, growing adoption of advanced allergy diagnostics kits & technology and increasing environmental pollution. Favorable reimbursement scenario in the U.S. is also playing a pivotal role in contributing to the growth of the market globally. However, lack of coverage for the test in emerging countries and issues related to affordability of allergy diagnostics instruments are likely to restrain the market growth to a certain extent. 

Allergy Diagnostics Market Report

 

Market Segmentation & Insights

The global allergy diagnostics market has been analyzed from five perspectives: Test Type, Product Type, Allergan Type, End User and Region. 

Allergy Diagnostics Market by Test Type

Based on test type, the allergy diagnostics market has been segmented into in vivo and in vitro. The in vivo tests include test, such as prick and intradermal skin tests, whereas, in vitro tests include tests such as RAST, MAST, FAST, ELISA, and ImmunoCAP. The in vivo segment holds the largest share in the market. The growth of the segment can be attributed to rising adoption of the test by healthcare professionals and patients due to its benefits such as ease of use, wider availability, and favorable reimbursement policies.

Allergy Diagnostics Market by Product Type

Based on product type, the allergy diagnostics market has been segmented into instruments, consumables and services. The consumables segment holds the largest share in the market. Consumable’s segment consists of the kits, reagents and other components of allergy diagnostics. The growth of the segment can be attributed to easy accessibility of diagnostic kits and their frequent purchase for each test performed as compared to the one-time purchase of instruments.

Allergy Diagnostics Market by Allergan Type

Based on allergen type, the market has been segmented into drug allergens, inhaled allergens, food allergens and others. The food allergens segment is expected to be the fastest growing segment during the forecast period owing to growing prevalence of food allergies especially in children. Researchers estimate that around 32 million Americans have food allergies, including 5.6 million children under the age of 18. According to FARE (Food Allergy Research & Education), each year around 200,000 people in the U.S. require emergency medical care for allergic reactions to food.

Allergy Diagnostics Market by End User

Based on end user, the allergy diagnostics market has been segmented into hospitals, diagnostic laboratories, academic research institutes and others. The diagnostic laboratories segment holds the largest share in the market. The growth of the market can be attributed to availability of advanced diagnostic kits & technology and increasing number of immunoassay tests performed for allergy diagnostics.

Allergy Diagnostics Market by Region

Based on region, the global allergy diagnostics market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the allergy diagnostics market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to its well-developed healthcare facilities, growing prevalence of various type of allergies, increasing adoption of highly advanced allergy diagnostics, favorable reimbursement scenario and presence of prominent players in the region.

Competitive Landscape

The allergy diagnostics market is marked by presence of prominent players such as Siemens Healthcare Private Limited, Thermo Fisher Scientific, bioMérieux SA, Hitachi Chemical Diagnostics, Inc., Omega Diagnostics Group PLC, StatNano, HYCOR Biomedical, Lincoln Diagnostics, Inc., Stallergenes Greer and HOB Biotech Group Corp., Ltd. Other players operating in the market are R-Biopharm AG, Alcon, among others.

Snapshot: Industry Developments 

• In Apr 2021, Mayo Clinic, a nonprofit organization committed to innovation in clinical practice, education & research, and Thermo Fisher Scientific joined forces to bring innovative solutions to patients by accelerating clinical validation, and commercialization of selected next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. The collaborative effort will leverage NGS, mass spectrometry and immunology technologies to advance hematology, oncology, allergy and autoimmunity diagnostics

• In Feb 2021, The Food Allergy Science Initiative (FASI) announced it beginning as a separate, independent organization dedicated to discovering the root causes of food allergies through rigorous scientific research and deploying new therapies to treat and ultimately cure them

• In Jun 2020, AllerGenis LLC, a data-driven precision diagnostics company focused on food allergies, announced the onset of operations at its Hatfield facility to test patient samples using its VeriMAPTM Peanut Diagnostic, a diagnostic solution for patients with peanut allergies

• In Jan 2020, AllerGenis, LLC announced that it has entered into a non-exclusive agreement with Luminex Corporation. According to the terms of the agreement, AllerGenis will have the rights to develop, market and sell its novel precision food allergy diagnostic assay using Luminex’s xMAP® Technology

• In Jan 2019, AllerGenis announced a non-exclusive deal with Luminex for use of the company's xMAP technology to develop, market, and sell a precision food allergy diagnostic assay

• In Dec 2018, Hycor Biomedical, a manufacturer of in vitro diagnostic products for allergy and autoimmune testing, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new allergy testing system, NOVEOS

Key Insights Captured in the Report

• Quantitative (market size and forecasts) and qualitative insights of the market across years - historical years, current year and forecasted years 

• Deep-rooted insights on headwinds, tailwinds and opportunities prevailing in the market

• Quantitative (market size and forecasts) and qualitative insights at segment and sub-segment level

• Comprehensive quantitative (market size and forecasts) and qualitative insights on geographic, regional and country level markets

• Granular insights on the competitive landscape prevailing in the market

• Competitive mapping of strategic developments 

Scope of the Allergy Diagnostics Market Report

Report Metrics Details
Market Size Period 2018-2031
Base Year 2020
Forecast Period 2021-2031
Market Segments Asessment of Allergy Diagnostics Market By:
• Test Type
• Product Type
• Allergen Type
• End-User
• Region
Geographic Scope North America
◦ U.S.
◦ Canada
Europe
◦ Germany
◦ UK
◦ France
◦ Rest of Europe (RoE)
Asia Pacific
◦ China
◦ Japan
◦ India
◦ Rest of Asia Pacific (RoAPAC)
Rest of the World
◦ Latin America
◦ Middle East & Africa
Companies Covered Siemens Healthcare Private Limited, Thermo Fisher Scientific, bioMérieux SA, Hitachi Chemical Diagnostics, Inc., Omega Diagnostics Group PLC, StatNano, HYCOR Biomedical, Lincoln Diagnostics, Inc., Stallergenes Greer and HOB Biotech Group Corp., Ltd., R-Biopharm AG, Alcon, among others.

1 RESEARCH ENVELOPE

1.1 Market Classification

1.2 Scope of the Study

1.2.1 Timeline Considered for Market Study

· Historic Years – 2018 & 2019

· Base Year – 2020

· Projected Years – 2021 to 2031

1.3 Currency Used in the Report

2 RESEARCH METHODOLOGY

2.1 Research Approach

2.2 Data Collection Methodology

2.3 Data Sources

2.3.1 Secondary Sources

2.3.2 Primary Sources

2.4 Market Crackdown Methodology

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Data Forecasting Model

2.6 Limitations and Assumptions for Study

3 HEADWINDS & TAILWINDS ASSESSMENT

4 MARKET OPPORTUNITIES ASSESSMENT

5 PREMIUM INSIGHTS

5.1 Key Market Trends

5.2 Key Players & Their Competitive Positioning (2020)

5.3 COVID-19 Impact Assessment

6 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY TEST TYPE

6.1 In Vivo

6.2 In Vitro

7 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE

7.1 Instruments

7.1.1 ELISA Analyzers

7.1.2 Luminometers

7.1.3 Other Instruments

7.2 Consumables

7.3 Services

8 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY ALLERGEN TYPE

8.1 Drug Allergens

8.2 Inhaled Allergens

8.3 Food Allergens

8.4 Others

9 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY END USER

9.1 Hospitals

9.2 Diagnostic Laboratories

9.3 Academic Research Institutes

9.4 Others

10 GLOBAL ALLERGY DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY REGION

10.1 North America Allergy Diagnostics Market

10.1.1 North America Allergy Diagnostics Market, By Country

10.1.1.1 U.S.

10.1.1.2 Canada

10.1.2 North America Allergy Diagnostics Market, By Test Type

10.1.3 North America Allergy Diagnostics Market, By Product Type

10.1.4 North America Allergy Diagnostics Market, By Allergen Type

10.1.5 North America Allergy Diagnostics Market, By End User

10.2 Europe Allergy Diagnostics Market

10.2.1 Europe Allergy Diagnostics Market, By Country/Region

10.2.1.1 Germany

10.2.1.2 U.K

10.2.1.3 France

10.2.1.4 Rest of Europe (ROE)

10.2.2 Europe Allergy Diagnostics Market, By Test Type

10.2.3 Europe Allergy Diagnostics Market, By Product Type

10.2.4 Europe Allergy Diagnostics Market, By Allergen Type

10.2.5 Europe Allergy Diagnostics Market, By End User

10.3 Asia Pacific Allergy Diagnostics Market

10.3.1 Asia Pacific Allergy Diagnostics Market, By Country/Region

10.3.1.1 China

10.3.1.2 Japan

10.3.1.3 India

10.3.1.4 Rest of Asia Pacific (RoAPAC)

10.3.2 Asia Pacific Allergy Diagnostics Market, By Test Type

10.3.3 Asia Pacific Allergy Diagnostics Market, By Product Type

10.3.4 Asia Pacific Allergy Diagnostics Market, By Allergen Type

10.3.5 Asia Pacific Allergy Diagnostics Market, By End User

10.4 Rest of the World (RoW) Allergy Diagnostics Market

10.4.1 Rest of the World Allergy Diagnostics Market, By Region

10.4.1.1 Latin America

10.4.1.2 Middle East & Africa

10.4.2 Rest of The World Allergy Diagnostics Market, By Test Type

10.4.3 Rest of The World Allergy Diagnostics Market, By Product Type

10.4.4 Rest of The World Allergy Diagnostics Market, By Allergen Type

10.4.5 Rest of The World Allergy Diagnostics Market, By End User

11 COMPANY PROFILES

11.1 Siemens Healthcare Private Limited

11.1.1 Business Overview

11.1.2 Financial Metrics*

11.1.3 Product & Services Portfolio

11.1.4 Key Developments

11.2 Thermo Fisher Scientific

11.3 bioMérieux SA

11.4 Hitachi Chemical Diagnostics, Inc.

11.5 Omega Diagnostics Group PLC

11.6 StatNano

11.7 HYCOR Biomedical

11.8 Lincoln Diagnostics, Inc.

11.9 Stallergenes Greer

11.10 HOB Biotech Group Corp., Ltd

*Insights on financial metrics is subject to availability of information in the public domain

Download Report Sample PDF

Specific Requirement Form

Solitary

  • The solitary license authorizes only one individual to use the report
  • A PDF version of the report will be delivered that can be viewed on only one authorized system
  • Free analyst support for 20 hours is extended as a value-added service
  • Buyers need to share the ‘Name and Email ID of the authorized user
  • Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research

$4850

Compound

  • Compound license authorizes only 5 individuals to use the report
  •  A PDF/Printable version of report will be delivered that can be viewed on only 5 authorized systems
  • Free analyst support for 40 hours is extended as a value-added service
  • Buyers need to share ‘Names and Email IDs’ of the authorized users 
  • Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research

$5850

Corporate

  • Corporate license authorizes unlimited individuals to use the report
  • A PDF/Printable version of report will be delivered that can be viewed on unlimited systems
  • Free analyst support for 80 hours is extended as a value-added service
  • This license type allows extraction of top-level market data tables in ‘Excel’ format and also permits the buyer to quote the contents of the report published by Clairvoyance Research

$6850

Data Pack

  • Data Pack’ request provides customers all ‘Quantitative Insights’ with respect to a particular market in an excel-based dashboard format

$2250

Purchase Options

Solitary $4850

Compound $5850

Corporate $6850

Data Pack $2250

  • The solitary license authorizes only one individual to use the report
  • A PDF version of the report will be delivered that can be viewed on only one authorized system
  • Free analyst support for 20 hours is extended as a value-added service
  • Buyers need to share the ‘Name and Email ID of the authorized user
  • Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research

Popular Reports

Summer 3E,Purti Season,22 Buroshibtalla Main Road, Near Leela Petrol Pump, Kolkata, West Bengal-700038
+ 91 8761988338
10 AM to 10 PM
info@clairvoyanceresearch.com
Support line
TOP